- ►diabetesjournals.org CA Houlihan, A Akdeniz, C Tsalamandris, ME … - Diabetes Care, 2002 - Am Diabetes Assoc OBJECTIVE—Transforming growth factor-β (TGF-β) is a prosclerotic growth
factor implicated in the pathogenesis of diabetic nephropathy. In addition to
high glucose, other factors implicated in renal fibrosis and increased ... Cited by 77 - Related articles - BL Direct - All 6 versions
[CITATION] Connective tissue growth factor and regulation of the mesangial cell cycle: role in cellular …
CG Densem, ASM Mutlak, V Pravica, NH … - Transplant Immunology, 2004 - Elsevier Background: Coronary vasculopathy (CV) is an important determinant of survival
following cardiac transplantation. We have previously shown that G915C
polymorphism of the Transforming Growth Factor-β1 (TGF-β1) gene strongly ... Cited by 34 - Related articles - All 2 versions
F Citterio, U Pozzetto, J Romagnoli, E Tondolo … - Transplantation proceedings, 2004 - Elsevier Experimental and clinical evidence support the role of transforming growth
factor beta-1 (TGF-β 1 ), a cytokine with complex immune and nonimmune effects,
on the development of chronic renal allograft nephropathy (CAN). We ... Cited by 43 - Related articles - All 8 versions
E Esmatjes, L Flores, P Inigo, S Lario, LM … - Nephrology Dialysis Transplantation, 2001 - ERA-EDTA Results. At 4 and 8 weeks of treatment, a reduction was observed in TGF-ß1
plasma levels (5.5±4.5 vs 2.0±0.6 and 2.6±1.0 ng/ml, P<0.005), UAE (96±65 vs
59±59 and 64±47 µg/min, P<0.01), 24-h systolic blood pressure (136±9 vs ... Cited by 43 - Related articles - BL Direct - All 4 versions
W Yang… - Transplantation, 2003 - journals.lww.com Background. Combined treatments of mycophenolate mofetil (MMF) and losartan
(LSRT) have synergistic ef- fects on various renal diseases through their
hemody- namic and anti-inflammatory effects. This study investi- gated ... Cited by 74 - Related articles - BL Direct - All 6 versions
R Agarwal, S Siva, SR Dunn, K Sharma - American Journal of Kidney Diseases, 2002 - Elsevier Progression of renal failure, despite renoprotection with angiotensin-converting
enzyme (ACE) inhibitors in patients with proteinuric nephropathies, may be
caused by persistent renal production of transforming growth factor-[beta ... Cited by 104 - Related articles - BL Direct - All 7 versions
K Amann, A Koch, J Hofstetter, ML Gross, C … - Kidney international, 2001 - nature.com Male Sprague-Dawley rats were subjected to surgical ablation (SNX) or sham
operation (sham). Three days after surgery groups were treated either with
phenoxybenzamine (PBZ, 5 mg/kg body weight/day), metoprolol (MET, 150 mg/kg ... Cited by 82 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org RG Langham, DJ Kelly, RM Gow, Y Zhang, DJ … - Diabetes care, 2006 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—RNA was extracted from renal biopsies taken from
participants in the Diabiopsies study, a randomized controlled 2-year trial of 4
mg/day perindopril versus placebo that reported a reduction in proteinuria ... Cited by 16 - Related articles - BL Direct - All 6 versions
- ►clinchem.org D Ellis, KYZ Forrest, J Erbey, TJ Orchard - Clinical chemistry, 1998 - Am Assoc Clin Chem Urinary samples were concentrated rapidly and efficiently and were used to
develop several protein assays that may be of value in monitoring individuals
with progressive renal disorders. Transforming growth factor-ß1 (TGF-ß1) ... Cited by 90 - Related articles - BL Direct - All 4 versions
